MHRA — authorised 29 June 2017
- Marketing authorisation holder: Pfizer Limited
- Status: approved
MHRA authorised Besponsa on 29 June 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA authorised it on 29 June 2017.
Pfizer Limited holds the UK marketing authorisation.